Tissue ablation technologies for localized prostate cancer
| Autor: | Matthew T. Gettman, Horst Zincke, Michael D. Gillett, Michael L. Blute |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Risk Assessment Prostate cancer Periprostatic Prostate medicine Humans Neoplasm Invasiveness Transurethral resection of the prostate Aged Neoplasm Staging Randomized Controlled Trials as Topic medicine.diagnostic_test business.industry Prostatic Neoplasms General Medicine Middle Aged medicine.disease Prognosis High-intensity focused ultrasound Surgery Radiation therapy Survival Rate Prostate-specific antigen medicine.anatomical_structure Treatment Outcome Catheter Ablation Transrectal ultrasonography Radiology business Forecasting |
| Zdroj: | Mayo Clinic proceedings. 79(12) |
| ISSN: | 0025-6196 |
| Popis: | Traditional treatments for men with localized prostate cancer have included both surgical removal and radiation therapy, with their potential adverse effects on patient quality of life. Thus, there has been increasing interest in the development of minimally invasive procedures that use various technologies to deliver lethal doses of heat or cold to the prostate in an attempt to kill cancer cells. At the same time, it is vital that these newer techniques ablate prostate tissue and spare vital periprostatic organs essential for maintaining function and quality of life. In this article, we evaluate the current status of tissue ablation modalities in the treatment of clinically localized prostate cancer, focusing on the different methods, early results, and possible future directions. Although still in the beginning stages, these newer forms of treatment offer exciting potential for first-line and second-line treatment of this common urologic malignancy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|